Company Focus

Merck & Co

Latest Merck & Co News

Merck & Co buoyed by Phase III results with HIV tablet
Pharmaceutical
US pharma giant Merck has announced top-line results from two pivotal Phase III trials of the investigational, once-daily, oral, two-drug, single-tablet regimen of doravirine/islatravir (DOR/ISL).   20 December 2024


Latest News & Features of interest to Merck & Co

Latest In Brief for Merck & Co

Biotechnology
The Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) in Mexico has approved humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody Leqembi (lecanemab) for the treatment of early Alzheimer’s disease (AD).   5 December 2024

Latest Related Ones To Watch News

Venture capital firm BC Partners has entered into an agreement under which the private equity business at Goldman Sachs Alternatives will acquire a majority stake in Netherlands-based Synthon, from funds advised by BC Partners.   17 December 2024

More in M&A >


Related Ones to Watch Companies

Reset all filters
Refine Search